BIODELIVERY SCIENCES INTERNATIONAL INC - FORM 10-K - EX-21.1 - March 11, 2021

Attached files

file filename
EX-10.32 - EX-10.32 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi1032pleshaamendment.htm
EX-32.2 - EX-32.2 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi-20201231x10qex322.htm
EX-32.1 - EX-32.1 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi-20201231x10qex321.htm
EX-31.2 - EX-31.2 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi-20201231x10kex312.htm
EX-31.1 - EX-31.1 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi-20201231x10qex311.htm
EX-23.2 - EX-23.2 - BIODELIVERY SCIENCES INTERNATIONAL INCa2020exhibit232.htm
EX-23.1 - EX-23.1 - BIODELIVERY SCIENCES INTERNATIONAL INCa2020exhibit231.htm
EX-10.33 - EX-10.33 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi1033baileyofferlette.htm
EX-10.31 - EX-10.31 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi1031coelhoamendment.htm
EX-10.30 - EX-10.30 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi1030vollinsamendment.htm
EX-4.1 - EX-4.1 - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi41securities.htm
10-K - 10-K - BIODELIVERY SCIENCES INTERNATIONAL INCbdsi-20201231.htm

Exhibit 21.1
Subsidiaries of the Registrant
1.    Arius Pharmaceuticals, Inc., a Delaware corporation
2.    Arius Two, Inc., a Delaware corporation

BIODELIVERY SCIENCES INTERNATIONAL INC Reports